Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Adolph Lombardi

Adult Reconstructive Orthopaedic Surgery New Albany, OH Medical Doctor

NPI 1700879186 CMS profile 259334

7277 Smiths Mill Rd Ste 200, New Albany, OH 43054

Open in the dashboard

General payments

$14,723,853

775 records reported · program years 2019–2025

Research payments

$5,934

Paid to them · 2 records reported · program years 2019–2025

Ownership & investment interest

$1,358,576

7 holdings reported · through program year 2025

Research they led as principal investigator

$242,517 paid to institutions, not to them · program years 2019–2024

Through program year 2025, Adolph Lombardi of New Albany, OH is reported in the CMS Open Payments database as having received $14,723,853 across 775 general payments and $5,934 in research payments paid to them. Separately, studies naming them as principal investigator received $242,517 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $1,358,576 across 7 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Adult Reconstructive Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

15 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,010,952 190
2024 General $1,880,954 195
2023 General $2,743,007 143
2022 General $2,285,962 70
2021 General $1,928,368 56
2021 Research $5,934 2
2020 General $1,798,906 45
2019 General $2,075,705 76
2025 Ownership $150,953 1
2024 Ownership $150,953 1
2023 Ownership $150,953 1
2022 Ownership $150,953 1
2021 Ownership $150,953 1
2020 Ownership $301,906 1
2019 Ownership $301,906 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Adolph Lombardi
  • Adult Reconstructive Orthopaedic Surgery median
  • Middle half of Adult Reconstructive Orthopaedic Surgery
  • National median

In program year 2025, general payments to Adolph Lombardi were reported at $2,010,952. Among 1,079 Adult Reconstructive Orthopaedic Surgery profiles paid that year, the median was $1,406 and the middle half received between $318 and $8,709.

Show as a table
Year Adolph Lombardi Adult Reconstructive Orthopaedic Surgery median Middle half National median
2019 $2,075,705 $1,416 $292–$9,336 $163
2020 $1,798,906 $647 $141–$6,474 $114
2021 $1,928,368 $1,073 $211–$6,497 $132
2022 $2,285,962 $1,217 $236–$6,299 $149
2023 $2,743,007 $1,082 $246–$6,818 $160
2024 $1,880,954 $1,575 $323–$8,944 $164
2025 $2,010,952 $1,406 $318–$8,709 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $14,704,387 749 payments
  2. Cardinal Health 200, LLC $6,000 1 payment
  3. Regeneron Pharmaceuticals, Inc. $5,476 5 payments
  4. Kinamed, Inc. $3,000 1 payment
  5. restor3d, inc. $2,581 3 payments
  6. Flexion Therapeutics, Inc. $1,400 1 payment
  7. Heron Therapeutics, Inc. $264 2 payments
  8. Davol Inc. $259 4 payments
  9. Becton, Dickinson and Company $223 3 payments
  10. Engage Uni, LLC $114 1 payment
  11. Other $149 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $12,420,602 101 payments
  2. Consulting Fee $1,723,851 136 payments
  3. Education $486,333 107 payments
  4. Travel and Lodging $77,583 201 payments
  5. Food and Beverage $12,870 228 payments
  6. Honoraria $2,500 1 payment
  7. Gift $114 1 payment
Products named General payments · program years 2019–2025
  1. Vanguard $3,763,653 29 payments
  2. Persona Knees $3,743,562 33 payments
  3. Taperloc Hips $3,718,003 22 payments
  4. Trabecular Metal (TM) $3,712,003 19 payments
  5. Vanguard Complete Knee Solution $3,239,801 21 payments
  6. Persona Knees $2,149,210 153 payments
  7. Oxford $1,980,016 18 payments
  8. Taperloc Hips $1,914,011 18 payments
  9. Oxford-Knees $1,911,020 14 payments
  10. Persona Knees $1,910,645 14 payments
  11. Other $8,719,721 407 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $5,934 2 payments

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

130

Median for Orthopedic Surgery: 203

Drug cost

$2,640

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 58 $2,142
Diclofenac Sodium Generic 20 $160
Methylprednisolone Generic 22 $139
Ondansetron Hcl Generic 13 $117
Cephalexin Generic 17 $81

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 54 billing codes

Paid by Medicare

$468,514

Of which drugs: $2,380

Medicare patients

642

Average age 73

Services billed

2,708

400 women, 242 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 74%
Diabetes 26%
Ischemic heart disease 22%
Depression 21%
Chronic kidney disease 19%
Cancer 15%
Osteoporosis 15%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 43 213 $161
Injection, bupivicaine, not otherwise specified, 0.5 mg J0665 Office 19 82 $1

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

777 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Adult Reconstructive Orthopaedic Surgery in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record